Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues

Details for Australian Patent Application No. 2006214032 (hide)

Owner Medarex, Inc.

Inventors Zhu, Lei; Cardarelli, Josephine M.; Albanese, Jenny; Passmore, David B.

Agent Shelston IP

Pub. Number AU-B-2006214032

PCT Pub. Number WO2006/089231

Priority 60/660,431 09.03.05 US; 60/654,266 18.02.05 US

Filing date 17 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 8 March 2012

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089231 Priority application(s): WO2006/089231

8 March 2012 Application Accepted

  Published as AU-B-2006214032

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214033-Monoclonal antibodies against CD30 lacking fucosyl residues

2006214031-Human monoclonal antibodies to prostate specific membrane antigen (PSMA)